Search
Patexia Research
Case number 1:20-cv-01297

Otsuka Pharmaceutical Co., Ltd. et al v. Amneal Pharmaceuticals LLC et al > Documents

Date Field Doc. No.Description (Pages)
Dec 29, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (14 in 1:20-cv-01297-LPS, 420 in 1:19-cv-01938-LPS) STIPULATION Regarding Partial Dismissal of Claims Without Prejudice, and Regarding Consolidation (Amneal) filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 12/28/21. Associated Cases: 1:19-cv-01938-LPS, 1:20-cv-01297-LPS (ntl)
Dec 29, 2021 N/A Create Case Association (0)
Docket Text: Case associated with lead case: Create association to 1:19-cv-01938-LPS. (ntl)
Dec 21, 2021 14 Stipulation (5)
Docket Text: STIPULATION Regarding Partial Dismissal of Claims Without Prejudice, and Regarding Consolidation (Amneal), by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Mayo, Andrew)
Mar 19, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [13] STIPULATION Regarding Dismissal of Claims Against Certain Defendants Without Prejudice, and Amendment of Case Caption -- Party Amneal Pharmaceuticals, Inc., Amneal EU, Ltd. and Amneal Pharmaceuticals of New York, LLC terminated. Signed by Judge Leonard P. Stark on 3/18/21. (ntl)
Mar 18, 2021 13 Stipulation (5)
Docket Text: STIPULATION Regarding Dismissal of Claims Against Certain Defendants Without Prejudice, and Amendment of Case Caption, by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Balick, Steven)
Jan 15, 2021 11 Answer to Complaint (24)
Docket Text: ANSWER to [1] Complaint, by Amneal EU, Ltd., Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals, Inc., Raks Pharma Pvt. Ltd..(Gaza, Anne)
Jan 15, 2021 12 Disclosure Statement (5)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Amneal Pharmaceuticals LLC for Amneal Pharmaceuticals of New York, LLC; Corporate Parent Amneal Pharmaceuticals Holding GmbH for Amneal EU, Ltd., Amneal Pharmaceuticals Company GmbH; Other Affiliate Amneal Singapore Pvt. Ltd. for Raks Pharma Pvt. Ltd.; Corporate Parent Amneal Pharmaceuticals Holding Company LLC, Corporate Parent Amneal Pharmaceuticals, Inc. for Amneal Pharmaceuticals LLC filed by Amneal EU, Ltd., Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals, Inc., Raks Pharma Pvt. Ltd.. (Gaza, Anne)
Jan 14, 2021 N/A Add Attorneys Pro Hac Vice (0)
Docket Text: Pro Hac Vice Attorneys Denise Main, Erin M. Sommers, C. Collette Corser, Tyler B. Latcham for H. Lundbeck A/S and Otsuka Pharmaceutical Co., Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-01287-LPS et al.(kmd)
Jan 5, 2021 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re (14 in 1:20-cv-01365-LPS, 8 in 1:20-cv-01287-LPS, 13 in 1:20-cv-01296-LPS, 9 in 1:20-cv-01599-LPS, 7 in 1:20-cv-01428-LPS, 12 in 1:20-cv-01423-LPS, 11 in 1:20-cv-01335-LPS, 10 in 1:20-cv-01295-LPS, 7 in 1:20-cv-01581-LPS, 7 in 1:20-cv-01502-LPS, 7 in 1:20-cv-01763-LPS, 10 in 1:20-cv-01297-LPS, 11 in 1:20-cv-01332-LPS, 13 in 1:20-cv-01531-LPS) MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Denise Main, Erin M. Sommers, C. Collette Corser and Tyler B. Latcham filed by Otsuka Pharmaceutical Co.,Ltd, Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S, Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 1/5/21. Associated Cases: 1:20-cv-01287-LPS et al. (ntl)
Dec 31, 2020 10 Motion for Leave to Appear Pro Hac Vice (17)
Docket Text: MOTION for Pro Hac Vice Appearance of Attorney James B. Monroe, Denise Main, Erin M. Sommers, C. Collette Corser and Tyler B. Latcham - filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd., Otsuka Pharmaceutical Co.,Ltd, Otsuka Pharmaceutical Co. Ltd., H. Lundbeck A/S. (Mayo, Andrew)
Dec 30, 2020 N/A SO ORDERED (0)
Docket Text: SO ORDERED, re [7] STIPULATION Regarding Waiver of Service and Establishment of Answer Deadline filed by Otsuka Pharmaceutical Co., Ltd., H. Lundbeck A/S. Signed by Judge Leonard P. Stark on 12/30/20. (ntl)
Dec 23, 2020 7 Stipulation (2)
Docket Text: STIPULATION Regarding Waiver of Service and Establishment of Answer Deadline by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. (Mayo, Andrew)
Dec 23, 2020 8 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. Amneal Pharmaceuticals, Inc. served on 12/23/2020, answer due 1/13/2021. (Mayo, Andrew)
Dec 23, 2020 9 Summons Returned Executed (2)
Docket Text: SUMMONS Returned Executed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd.. Amneal Pharmaceuticals of New York, LLC served on 12/23/2020, answer due 1/13/2021. (Mayo, Andrew)
Sep 30, 2020 N/A Case Assigned/Reassigned (0)
Docket Text: Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. Associated Cases: 1:20-cv-01286-LPS, 1:20-cv-01287-LPS, 1:20-cv-01295-LPS, 1:20-cv-01296-LPS, 1:20-cv-01297-LPS (rjb)
Sep 28, 2020 N/A No Summons Issued (0)
Docket Text: No Summons Issued. (amf)
Sep 25, 2020 1 Main Document (13)
Docket Text: COMPLAINT FOR PATENT INFRINGEMENT - filed against Amneal EU, Ltd., Amneal Pharmaceuticals Company GmbH, Amneal Pharmaceuticals LLC, Amneal Pharmaceuticals of New York, LLC, Amneal Pharmaceuticals, Inc., and Raks Pharma Pvt. Ltd. - Magistrate Consent Notice to Pltf. (Filing fee $ 400, receipt number ADEDC-3225956) - filed by H. Lundbeck A/S, Otsuka Pharmaceutical Co., Ltd. (Attachments: # (1) Exhibit A-B, # (2) Civil Cover Sheet)(amf)
Sep 25, 2020 1 Exhibit A-B (57)
Sep 25, 2020 1 Civil Cover Sheet (4)
Sep 25, 2020 2 Magistrate Consent Forms (3)
Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (amf)
Sep 25, 2020 3 ANDA Form (2)
Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 8/17/2020. Date of Expiration of Patent: 4/12/2026 (*SEE ATTACHED FORM).Thirty Month Stay Deadline: 1/10/2023. (amf)
Sep 25, 2020 4 Patent/Trademark Report to Commissioner (1)
Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US RE48,059. (amf)
Sep 25, 2020 5 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Otsuka Holdings Co., Ltd. for Otsuka Pharmaceutical Co., Ltd. - filed by Otsuka Pharmaceutical Co., Ltd. (amf)
Sep 25, 2020 6 Disclosure Statement (2)
Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed - filed by H. Lundbeck A/S. (amf)
Sep 25, 2020 1 Complaint* (1)
Menu